E. Ljung

401 total citations
14 papers, 332 citations indexed

About

E. Ljung is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, E. Ljung has authored 14 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cellular and Molecular Neuroscience, 9 papers in Molecular Biology and 3 papers in Neurology. Recurrent topics in E. Ljung's work include Neurotransmitter Receptor Influence on Behavior (8 papers), Neuroscience and Neuropharmacology Research (7 papers) and Receptor Mechanisms and Signaling (6 papers). E. Ljung is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (8 papers), Neuroscience and Neuropharmacology Research (7 papers) and Receptor Mechanisms and Signaling (6 papers). E. Ljung collaborates with scholars based in Sweden, United States and Italy. E. Ljung's co-authors include Kjell Svensson, T Kling-Petersen, Peter Martin, Kaj Blennow, Linda Paulson, Pia Davidsson, Carol L. Nilsson, Ann Brinkmalm, Anders I. Persson and Peter S. Eriksson and has published in prestigious journals such as Brain Research, Journal of Pharmacology and Experimental Therapeutics and European Journal of Pharmacology.

In The Last Decade

E. Ljung

14 papers receiving 327 citations

Peers

E. Ljung

CMN

NEURO

Takeshi Iwazaki Australia

Geraldine T. Petr United States

M. H. Selina Mok United Kingdom

B. Grimaldi France

Zaiga Bleuel Switzerland

Claire Roberts United Kingdom

José Vicente Negrete‐Díaz Mexico

Elvar M. Eyjolfsson Norway

Tamotsu Nomura Japan

Elsa Regina Vinadé Brazil

Takeshi Iwazaki Australia

E. Ljung

307 ×1.4

CMN

154 ×0.8

46 ×0.9

67 ×1.6

22 ×0.6

NEURO

Citations per year, relative to E. Ljung E. Ljung (= 1×) peers Takeshi Iwazaki

Countries citing papers authored by E. Ljung

Since Specialization

Citations

This map shows the geographic impact of E. Ljung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Ljung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Ljung more than expected).

Fields of papers citing papers by E. Ljung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Ljung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Ljung. The network helps show where E. Ljung may publish in the future.

Co-authorship network of co-authors of E. Ljung

This figure shows the co-authorship network connecting the top 25 collaborators of E. Ljung. A scholar is included among the top collaborators of E. Ljung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Ljung. E. Ljung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Hjorth, Stephan, Nicholas Waters, Joakim Tedroff, et al.. (2020). (3S)‐3‐(2,3‐difluorophenyl)‐3‐methoxypyrrolidine (IRL752) —a Novel Cortical-Preferring Catecholamine Transmission- and Cognition-Promoting Agent. Journal of Pharmacology and Experimental Therapeutics. 374(3). 404–419. 4 indexed citations

Waters, Nicholas, Clas Sonesson, Peder Svensson, et al.. (2020). Preclinical Pharmacology of [2-(3-Fluoro-5-Methanesulfonyl-phenoxy)Ethyl](Propyl)amine (IRL790), a Novel Dopamine Transmission Modulator for the Treatment of Motor and Psychiatric Complications in Parkinson Disease. Journal of Pharmacology and Experimental Therapeutics. 374(1). 113–125. 18 indexed citations

Waters, Nicholas, et al.. (2016). In Vivo Systems Response Profiling and Multivariate Classification of CNS Active Compounds: A Structured Tool for CNS Drug Discovery. ACS Chemical Neuroscience. 8(4). 785–797. 11 indexed citations

Giorgioni, Gianfabio, et al.. (2008). Synthesis and Pharmacological Evaluation of 4-Phenoxy-1,2,3,4- Tetrahydroisoquinolines and 4,5,6,6a-Tetrahydrochromeno [2,3,4-de]isoquinolines. Medicinal Chemistry. 4(1). 1–10. 5 indexed citations

Paulson, Linda, Peter Martin, E. Ljung, Kaj Blennow, & Pia Davidsson. (2007). Proteome analysis after co-administration of clozapine or haloperidol to MK-801-treated rats. Journal of Neural Transmission. 114(7). 885–891. 10 indexed citations

Paulson, Linda, Peter Martin, Carol L. Nilsson, et al.. (2004). Comparative proteome analysis of thalamus in MK‐801‐treated rats. PROTEOMICS. 4(3). 819–825. 38 indexed citations

Paulson, Linda, Peter Martin, E. Ljung, Kaj Blennow, & Pia Davidsson. (2004). Effects on rat thalamic proteome by acute and subchronic MK-801-treatment. European Journal of Pharmacology. 505(1-3). 103–109. 10 indexed citations

Paulson, Linda, Peter Martin, Anders I. Persson, et al.. (2002). Comparative genome‐ and proteome analysis of cerebral cortex from MK‐801‐treated rats. Journal of Neuroscience Research. 71(4). 526–533. 75 indexed citations

Kling-Petersen, T, E. Ljung, Nicholas Waters, & Kjell Svensson. (1996). Effects on locomotor activity after local application of (+)-UH232 in discrete areas of the rat brain. Journal of Neural Transmission. 103(3). 331–341. 5 indexed citations

10.

Kling-Petersen, T, et al.. (1995). Effects of dopamine D3 preferring compounds on conditioned place preference and intracranial self-stimulation in the rat. Journal of Neural Transmission. 101(1-3). 27–39. 35 indexed citations

11.

Kling-Petersen, T, E. Ljung, & Kjell Svensson. (1995). Effects on locomotor activity after local application of D3 preferring compounds in discrete areas of the rat brain. Journal of Neural Transmission. 102(3). 209–220. 57 indexed citations

12.

Kling-Petersen, T, et al.. (1995). Effects of the dopamine D3-and autoreceptor preferring antagonist (???)-DS121 on locomotor activity, conditioned place preference and intracranial self-stimulation in the rat. Behavioural Pharmacology. 6(2). 107???115–107???115. 16 indexed citations

13.

Kling-Petersen, T, E. Ljung, & Kjell Svensson. (1994). The preferential dopamine autoreceptor antagonist (+)-UH232 antagonizes the positive reinforcing effects of cocaine and d-amphetamine in the ICSS paradigm. Pharmacology Biochemistry and Behavior. 49(2). 345–351. 19 indexed citations

14.

Piercey, Montford F., et al.. (1992). Antagonism of cocaine's pharmacological effects by the stimulant dopaminergic antagonists, (+)-AJ76 and (+)-UH232. Brain Research. 588(2). 217–222. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact